• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌的生物学预后参数。

Biological prognostic parameters in gastric carcinomas.

作者信息

Potecă T, Potecă A, Sajin M, Comănescu M

出版信息

Chirurgia (Bucur). 2014 May-Jun;109(3):347-54.

PMID:24956340
Abstract

Gastric cancer is the second leading cause of cancer mortality worldwide. (1) Gastric carcinogenesis involves a variety of factors including diet, habitual factors as well as environmental factors. (2,3) This study aimed to correlate clinicopathological parameters of the cases studied and PCNA and p53 expression using immunohistochemistry. The study group included a total of 32 patients that underwent gastrectomy for gastric cancer.The study parameters were represented by epidemiological aspects (age, sex), clinical characteristics (signs and symptoms),histopathological findings (pTNM staging and degree of differentiation, histological classification, lymph nodes status and presence of vascular invasion) and survival, and immunohistochemical analysis (p53 and PCNA expression) of the study group. Histopathological study showed that most of the cases(26 cases) were of the intestinal type and 6 cases of the diffuse type. Immunohistochemical analysis of p53 protein expression showed an average of 20.75% positive cells, while PCNA expression showed an average of 47.3%. In terms of survival there were 6 cases of death at intervals ranged from 2-189 days,5 cases had subsequent presentations over 12 months, while 8 patients were lost to follow-up. At the time of surgery, 6 patients had distant metastases, while 6 more developed them in a period of 2-12 months after surgery. Identification of biomolecules that highlight potentially aggressive tumors may help modulate the therapeutic approach after surgical resection.

摘要

胃癌是全球癌症死亡的第二大主要原因。(1)胃癌的发生涉及多种因素,包括饮食、习惯因素以及环境因素。(2,3)本研究旨在通过免疫组织化学将所研究病例的临床病理参数与PCNA和p53表达进行关联。研究组共纳入32例因胃癌接受胃切除术的患者。研究参数包括流行病学方面(年龄、性别)、临床特征(体征和症状)、组织病理学发现(pTNM分期和分化程度、组织学分类、淋巴结状态和血管侵犯情况)以及生存情况,还有研究组的免疫组织化学分析(p53和PCNA表达)。组织病理学研究表明,大多数病例(26例)为肠型,6例为弥漫型。p53蛋白表达的免疫组织化学分析显示平均阳性细胞率为20.75%,而PCNA表达显示平均为47.3%。在生存方面,有6例在2至189天期间死亡,5例在12个月后有后续表现,而8例患者失访。手术时,6例有远处转移,另有6例在术后2至12个月内出现远处转移。识别突出潜在侵袭性肿瘤的生物分子可能有助于调整手术切除后的治疗方法。

相似文献

1
Biological prognostic parameters in gastric carcinomas.胃癌的生物学预后参数。
Chirurgia (Bucur). 2014 May-Jun;109(3):347-54.
2
Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.成纤维细胞生长因子受体4蛋白表达与胃癌的临床病理特征
World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.
3
Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.p53和c-erbB-2表达与胃癌组织病理学特征、幽门螺杆菌感染及预后的关系
Hepatogastroenterology. 1997 Mar-Apr;44(14):604-9.
4
Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.polo样激酶1(PLK1)蛋白的表达可预测胃癌患者的生存期。
Oncology. 2006;70(2):126-33. doi: 10.1159/000093003. Epub 2006 Apr 26.
5
The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.胃癌中p53蛋白的免疫组化表达。与临床病理因素及患者生存率的相关性。
Rom J Morphol Embryol. 2010;51(2):249-57.
6
Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.口腔鳞状细胞癌侵袭前沿的 p53 和 PCNA 表达形式:与临床病理特征和预后的相关性。
J Oral Pathol Med. 2011 Oct;40(9):693-8. doi: 10.1111/j.1600-0714.2011.01032.x. Epub 2011 Apr 18.
7
Gastric cancer: correlation between clinicopathological factors and survival of patients. II.胃癌:临床病理因素与患者生存率的相关性。II.
Rom J Morphol Embryol. 2009;50(2):185-94.
8
Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer.胃癌发生过程中p53表达的临床病理特征及时间顺序
Hepatogastroenterology. 2013 Nov-Dec;60(128):2113-8.
9
Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.信号转导子和转录激活子 3 的组成性激活与人类胃癌的更好预后、细胞增殖和缺氧诱导因子-1α相关。
Pathobiology. 2011;78(6):295-301. doi: 10.1159/000321696. Epub 2011 Nov 18.
10
P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.P53蛋白在胃腺癌中的表达。术后辅助化疗后生存的阴性预测指标。
Anticancer Res. 2000 Sep-Oct;20(5C):3929-33.

引用本文的文献

1
Overview of MDM2 and B-RAF Expression in Gastric Lesions.胃病变中MDM2和B-RAF表达概述
Open Access Maced J Med Sci. 2018 Oct 10;6(10):1795-1802. doi: 10.3889/oamjms.2018.338. eCollection 2018 Oct 25.
2
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis.增殖细胞核抗原表达在胃癌中的预后价值及临床病理意义:一项系统评价与Meta分析
Onco Targets Ther. 2017 Jan 10;10:319-327. doi: 10.2147/OTT.S126551. eCollection 2017.